United States· US:71335-3063_89eba7bc-b9e6-4132-901c-7c95963039e0
Flecainide Acetate
A flecainide product containing flecainide acetate, registered in United States by Bryant Ranch Prepack. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Flecainide is registered in 18 of 19 countries.
Countries holding a registration under ATC C01BC04 (flecainide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Flecainide · ATC C01BC04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of flecainide costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.49 in France to $2.20 in Switzerland — a ×4.5 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Flecainide · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.20
- IT Italy$0.70
- ES Spain$0.61
- FR France$0.49
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FLECAINIDE ACETATE
- Manufacturer
- Bryant Ranch Prepack
- Country
- United States (US)
- ATC code
- C01BC04
- ATC class
- Flecainide
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 10
- ndc11713353063130 TABLET in 1 BOTTLE (71335-3063-1)
- ndc11713353063260 TABLET in 1 BOTTLE (71335-3063-2)
- ndc11713353063390 TABLET in 1 BOTTLE (71335-3063-3)
- ndc117133530634180 TABLET in 1 BOTTLE (71335-3063-4)
- ndc117133530635100 TABLET in 1 BOTTLE (71335-3063-5)
- ndc1171335-3063-3
- ndc1171335-3063-1
- ndc1171335-3063-2
- ndc1171335-3063-4
- ndc1171335-3063-5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
342 interactions on record for flecainide.
Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flecainide · interactions on record
342 records
- 42 severe
- 164 moderate
- 15 minor
- 75 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- EliglustatA16AX10severe
46 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Flecainide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFlecainide 100mg tabletsMedihealth (Northern) Ltd
- ItalyALMARYTMVIATRIS HEALTHCARE LIMITED
- CanadaAG-FLECAINIDEANGITA PHARMA INC.
- FinlandFlecainid ActavisActavis Group PTC ehf
- NetherlandsFlecainide Alkaloid-INT 100 mg tablettenAlkaloid - INT d.o.o.
- FranceFLECAINE 100 mg, comprimé sécableVIATRIS MEDICAL
- SpainAPOCARD 100 mg COMPRIMIDOSViatris Healthcare Limited
- SwedenTambocor 100 mg Tablett2care4 ApS
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Aristocor
- Belgium · Apocard Retard, Flecainide Retard Eg
- Bulgaria · Амаритон, Фелкарид
- Cyprus · Flecardia
- Czechia · Amarhyton, Amarhyton 100 Mg
- Germany · Flecadura, Flecainid
- Denmark · Flecainid Sandoz, Flecainid Stada
- Spain · Apocard, Flecainida Aurovitas
- Finland · Flecainide Orion, Tambocor
- France · Flecaine, Flecaine L.P.
- United Kingdom (Northern Ireland) · Flecainide Acetate Accord-Uk, Flecainide Acetate Brown & Burk Uk
- Greece · Amarhyton, Flecainide/Flexmed
- Croatia · Felkarid
- Ireland · Flecainide Teva, Tambocor
- Iceland · Flecainid Stada, Tambocor
- Italy · Almarytm, Flecainide Aurobindo
- Luxembourg · Apocard Retard, Flecainide Retard Eg
- Malta · Flecainide Acetate Aurobindo Pharma (Malta), Tambocor
- Netherlands · Flecainide Acetate Aurobindo, Flecainide Acetate Ratiopharm
- Norway · Flecainid Sandoz, Tambocor
- Poland · Flecainide Acetate Holsten
- Portugal · Amarhyton, Apocard
- Romania · Amarhyton, Tambocor
- Sweden · Tambocor, Tambocor Retard
- Slovenia · Felkarid
- Slovakia · Amarhyton 100 Mg, Amarhyton 50 Mg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/80ea2f43-4cf7-429e-8521-e40147b24e08 GET /v1/drugs/80ea2f43-4cf7-429e-8521-e40147b24e08?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "FLECAINIDE ACETATE",
"productndc": "71335-3063",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA215599",
"marketing_category": "ANDA"
}See everything about flecainide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.